TScan Therapeutics, Inc.
NASDAQ:TCRX
2.63 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -89.218 | -66.221 | -48.625 | -26.127 | -13.658 |
| Depreciation & Amortization
| 5.361 | 5.137 | 3.328 | 1.23 | 0.519 |
| Deferred Income Tax
| 0 | 0 | -9.162 | 0 | 0 |
| Stock Based Compensation
| 5.208 | 4.551 | 2.516 | 0.515 | 0.24 |
| Change In Working Capital
| 17.606 | -10.23 | -5.896 | 21.357 | 0.299 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.052 | 0.528 | 0.01 | 1.127 | 0.161 |
| Other Working Capital
| 17.658 | -10.758 | -5.906 | 20.23 | 0.138 |
| Other Non Cash Items
| -0.315 | 0.26 | 9.162 | 0.002 | 0.078 |
| Operating Cash Flow
| -61.358 | -66.503 | -48.677 | -3.023 | -12.522 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -3.146 | -4.225 | -9.941 | -4.238 | -1.247 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -77.613 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 20 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -60.759 | -4.225 | -9.941 | -4.238 | -1.247 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 29.354 | 0 | 0 | 0 |
| Common Stock Issued
| 42.414 | 0.193 | 89.647 | 0.288 | 34.812 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 93.029 | -0.191 | 100.021 | 0.288 | 34.812 |
| Financing Cash Flow
| 135.443 | 29.356 | 189.668 | 0.288 | 34.812 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 13.326 | -41.372 | 131.05 | -6.973 | 21.043 |
| Cash At End Of Period
| 138.39 | 125.064 | 166.436 | 35.386 | 42.359 |